Radionuclide Decorporation Agents for Radiation/Nuclear Emergencies: Project BioShield (R01)

The summary for the Radionuclide Decorporation Agents for Radiation/Nuclear Emergencies: Project BioShield (R01) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Radionuclide Decorporation Agents for Radiation/Nuclear Emergencies: Project BioShield (R01)
	CFDA Number:	93.855
	CFDA Description:	Allergy, Immunology and Transplantation Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-AI-06-030
	Document Type:	Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Mar 30, 2006
	Creation Date:	Mar 30, 2006
	Original Closing Date for Applications:	May 16, 2006
	Current Closing Date for Applications:	Information not provided
	Archive Date:	Jun 15, 2006
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	$4,000,000
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Special district governments City or township governments Public housing authorities/Indian housing authorities Private institutions of higher education Public and State controlled institutions of higher education County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Independent school districts Native American tribal governments (Federally recognized) For profit organizations other than small businesses State governments
Additional Information on Eligibility: Foreign institutions are not eligible to apply. Eligible agencies of the Federal Government are eligible to apply. Foreign institutions/organizations may apply as a subcontractor to qualifying U.S. domestic institutions/organizations
Grant Description: This is a funding opportunity announcement (FOA) to accelerate the development of safe and effective products to remove radionuclides from the body (decorporation) following nuclear contamination from any source. Specifically, candidate products will demonstrate an increase in efficiency and rate of radionuclide elimination from the body after contamination due to ingestion, inhalation or transdermal absorption.-In FY 2006, the NIAID intends to commit up to $4 million to support research projects focused on the development of novel radionuclide chelation and decorporation agents. -Support will be provided for up to $1 million in total costs per award for a project period not to exceed eighteen (18) months. -It is anticipated that 4-6 awards will be made in 2006. -This FOA will use the R01 funding mechanism. -Eligible organizations: For-profit organizations; Non-profit organizations; Public or private institutions, such as universities, colleges, hospitals, and laboratories; Units of State government; Units of local government; Eligible agencies of the Federal government; Domestic Institutions (Foreign institutions/organization may apply as a subcontractor to a qualifying U.S. domestic institution/organization).-Eligible principal investigators include experienced scientists with leadership and administrative skills commensurate with those required to lead an R01 or similar award mechanism. -Applicants may not submit more than one application in response to this FOA. -See Section IV.1 for application materials. -Send applications directly to NIAID not to CSR per instructions.-Special Review by NIAID per BioShield Act 2004-Telecommunications for the hearing impaired is available at: TTY 301-451-0088
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-06-030.html http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-06-030.html
Grant Announcement Contact: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Innovation for HIV Vaccine Discovery (R01); • NIAID Clinical Trial Implementation Cooperative Agreement (U01); • Therapeutics for Neurotropic Biodefense Toxins and Pathogens (R21/R33); • Strategies for the Protection of Pregnant Women and Infants Against Infectious Diseases (R01); • Predictive Biodosimetry: Discovery and Development of Biomarkers for Acute and Delayed Radiation Inj...; • Center for HIV/AIDS Vaccine Immunology (CHAVI); • Genomics of Transplantation Cooperative Research Program; • Asthma and Allergic Diseases Cooperative Research Centers; • Asthma and Allergic Diseases Cooperative Research Centers (U19); • Medical Countermeasures to Restore Gastrointestinal Function after Radiation Exposure: Project Biosh...